The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelinePostoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the ElderlyCognitive function in breast cancer survivors compared to healthy age- and education-matched women.Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.Cognitive problems among breast cancer survivors: loneliness enhances riskChemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionMemory and cancer: a review of the literatureCognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.Asiatic acid protects against cognitive deficits and reductions in cell proliferation and survival in the rat hippocampus caused by 5-fluorouracil chemotherapy.A meta-analysis of cognitive impairment following adult cancer chemotherapy.Cognitive Effects of Systemic Therapy in Patients with Breast CancerA prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Symptom management of affective and cognitive disturbance with a group of cancer survivorsBehavioral symptoms in patients with breast cancer and survivors.Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.Memory loss during lenalidomide treatment: a report on two casesReliability and validity of the CogState battery Chinese language version in schizophrenia.Lifestyle factors associated with cognitive functioning in breast cancer survivors.A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in ratsManagement of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical Research and Practice.Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatmentA 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional studyNeeds assessment of cancer survivors in ConnecticutCognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints.Assessing cognitive function in adults during or following chemotherapy: a scoping review.Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions.Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.
P2860
Q21146752-F1A49CEE-EA87-470E-AA37-5324626BAF36Q26773986-F28B1853-1B03-437D-A584-72501C59B739Q28086981-56D10C57-5D24-4537-ABDA-380305666D80Q30458869-BA45E514-5D8C-45A0-A0AB-53A2610ECE25Q30499383-8605B147-D2C4-41CA-9099-C7791E1D95F1Q33358246-BD5D2D02-C954-4F81-97D2-481A54650C62Q33360883-43AE9986-E317-4DE6-A92C-E7D33FBD3370Q33590378-18F41804-EA17-49CA-A094-53E53C3C785EQ33663544-E829EF2C-23B1-4DD3-BB14-07A71593FEC0Q33786586-1AC12982-BAF2-4784-8E3C-00DE0999B2D2Q33816589-4129F6FC-EBDB-45A1-A5A9-A63B0581A48DQ33888300-1F50A2EB-37B4-4089-8CF6-B65F9878182FQ34083459-644E5C8F-36D4-40A2-A823-2C8C50FB2109Q34095832-E952CA4A-58CC-4067-B8FC-47EC14AFB2C1Q34110937-8E2C839E-B2DA-4F57-AA7F-256A2C42E151Q34395112-9F1836F1-1E5B-4151-8250-649DB18E1D9DQ34604438-698A6E76-F4E2-4ED2-AA32-02CB7D17421BQ34674401-86D1605F-8492-4954-BB04-5948DDB91B0EQ34675620-12E57692-4CFF-4B6E-B338-984F5BA81A00Q34815323-D9EB6D68-53C5-4A8B-AE45-5C1000403C76Q34929303-9EFBB6F5-75AD-458E-8BED-468109430A86Q34984648-8965E893-59B9-4E96-9452-CAA18BF7D550Q35027932-2993E214-FAC6-4756-A79A-00A3373C1BFFQ35161191-0F5C38E7-866B-432B-B3B1-959E0F0A81F0Q35243657-9A5F830F-B21E-40AB-ADB5-61BB266CD80BQ35427635-72414813-7CF0-4A11-B2E8-8629CA7F6CF6Q35523936-090BB23B-1FB9-484F-ADA7-F125EB07F634Q35535907-3378CF67-DB00-4FCC-86E6-720C7C57B7F0Q35551034-D477B423-629D-4264-AF1F-95D644107F58Q35695833-F7AFC177-DC8C-4A7A-AE85-4FF12514F06CQ35742776-AA27D70F-0FAA-42B6-86E3-673E3328B791Q35834672-487DCB20-D190-4BD3-A35B-CAF16A194CD5Q35854268-AD7354B4-36E5-4414-A4C6-CCBA67151149Q35933336-4D7CAC39-BB31-42DF-8741-1CFFD1D73A35Q35986398-90BDE977-26AA-4023-95AB-FFC1728D55B4Q36127633-0970B9F0-B4F4-4FD7-BA08-57D19A1593E3Q36240745-66513A79-8C06-44A5-A7EA-CFEF6040B2AAQ36331164-F01227A6-A245-4053-9E6E-C20C0F01195DQ36359668-9E9BBEC6-4EAF-4ECD-A4E7-8DFD62D78041Q36373733-2F104680-3C5B-4B52-9491-6D95F9B22FD4
P2860
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The nature and severity of cog ...... sis of the current literature.
@ast
The nature and severity of cog ...... sis of the current literature.
@en
type
label
The nature and severity of cog ...... sis of the current literature.
@ast
The nature and severity of cog ...... sis of the current literature.
@en
prefLabel
The nature and severity of cog ...... sis of the current literature.
@ast
The nature and severity of cog ...... sis of the current literature.
@en
P2093
P1433
P1476
The nature and severity of cog ...... ysis of the current literature
@en
P2093
Antonietta Sanfilippo
LeAnn Weih
Marina G Falleti
P356
10.1016/J.BANDC.2005.05.001
P577
2005-06-21T00:00:00Z